Characterization of the CHK1 allosteric inhibitor binding site.
Vanderpool, D., Johnson, T.O., Ping, C., Bergqvist, S., Alton, G., Phonephaly, S., Rui, E., Luo, C., Deng, Y.L., Grant, S., Quenzer, T., Margosiak, S., Register, J., Brown, E., Ermolieff, J.(2009) Biochemistry 48: 9823-9830
- PubMed: 19743875 
- DOI: 10.1021/bi900258v
- Primary Citation of Related Structures:  
3JVR, 3JVS - PubMed Abstract: 
Checkpoint kinase 1 (CHK1) is a key element in the DNA damage response pathway and plays a crucial role in the S-G(2)-phase checkpoint. Inhibiting CHK1 is a therapeutic strategy involving abrogation of the G2/M mitotic checkpoint defense of tumor cells t ...